|
已选(0)清除
条数/页： 排序方式：
|
| Papillary Thyroid Micro Carcinoma: The Incidence of High-Risk Features and Its Prognostic Implications 期刊论文
FRONTIERS IN ENDOCRINOLOGY, 2019, 卷号: 10
作者: Gao, Rui; Jia, Xi; Liang, Yiqian; Fan, Kun; Wang, Xiaoxiao
  收藏 | 浏览/下载：34/0 | 提交时间：2019/11/19
|
| Combination of 131I-anti-endoglin monoclonal antibody and 5-fluorouracil may be a promising combined-modality radioimmunotherapy strategy for the treatment of hepatocellular carcinoma 期刊论文
Biotechnology and Biotechnological Equipment, 2018, 页码: 1-8
作者: Duan C.; Li Y.; Yang W.; Zhang C.
收藏 | 浏览/下载：7/0 | 提交时间：2019/12/11
|
| The analysis of bone metabolism in hospitalized patients with Graves disease and the changes after 131I therapy 期刊论文
Fudan University Journal of Medical Sciences, 2017, 卷号: 44, 期号: 2, 页码: 186-191
作者: Ma W.-J.; Lyu C.-Y.; Zhang Y.; Xu G.-P.; He S.-M.
收藏 | 浏览/下载：4/0 | 提交时间：2019/12/11
|
| 2015年美国甲状腺学会《成人甲状腺结节与分化型甲状腺癌诊治指南》解读：分化型甲状腺癌131I治疗新进展 期刊论文
2016, 卷号: 26, 期号: 1, 页码: 1-12
作者: 林岩松; 李娇
收藏 | 浏览/下载：2/0 | 提交时间：2020/01/04
|
| In Patients With Low- to Intermediate-Risk Thyroid Cancer, a Preablative Thyrotropin Level of 30 μIU/mL Is Not Adequate to Achieve Better Response to 131I Therapy 期刊论文
2016, 卷号: 41, 期号: 6, 页码: 454-8
作者: Zhao Teng; Liang Jun; Guo Zhenqing; Li Tianjun; Lin Yansong
收藏 | 浏览/下载：2/0 | 提交时间：2020/01/04 |
| Thyroid Cancer: Radiation Safety Precautions in 131I Therapy Based on Actual Biokinetic Measurements. 期刊论文
Radiology, 2014, 卷号: Vol.273 No.1, 页码: 211-219
作者: Liu B; Peng W; Huang R; Tian R; Zeng Y
收藏 | 浏览/下载：7/0 | 提交时间：2019/03/01 |
| A comparative study of influential factors correlating with early and late hypothyroidism after I-131 therapy for Graves' disease 期刊论文
Chinese medical journal, 2010, 卷号: 123, 期号: 12, 页码: 1528-1532
作者: WANG; Ren-fei; TAN; Jian; ZHANG
收藏 | 浏览/下载：4/0 | 提交时间：2019/12/04
|
| 碘-131标记重组人肿瘤坏死因子-α治疗荷人肝癌裸鼠的实验研究 学位论文
: 四川大学, 2008
作者: 龙亚红
收藏 | 浏览/下载：5/0 | 提交时间：2019/04/19
|
